E
Appili Therapeutics Inc. APLI.TO
TSX
Recommendation
Prev Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)
Weiss Ratings APLI.TO - TSX Click to
Compare
Click to
Compare
Click to
Compare
Rating E
Reward Index Very Weak
Risk Index Very Weak
Risk Grade E+
Reward Grade E
Rating Factors APLI.TO - TSX Click to
Compare
Click to
Compare
Click to
Compare
Dividend Index --
Growth Index Fair
Efficiency Index Very Weak
Solvency Index Very Weak
Total Return Index Weak
Volatility Index Weak
Beta / Standard Deviation APLI.TO - TSX Click to
Compare
Click to
Compare
Click to
Compare
Beta 0.38
Price History APLI.TO - TSX Click to
Compare
Click to
Compare
Click to
Compare
7-Day Total Return -12.50%
30-Day Total Return 16.67%
60-Day Total Return 16.67%
90-Day Total Return -12.50%
Year to Date Total Return 0.00%
1-Year Total Return -26.32%
2-Year Total Return 0.00%
3-Year Total Return -69.57%
5-Year Total Return -96.46%
52-Week High % Change -40.00%
52-Week Low % Change 20.00%
Price APLI.TO - TSX Click to
Compare
Click to
Compare
Click to
Compare
52-Week High Price $0.05
52-Week Low Price $0.03
52-Week Low Price (Date) Sep 20, 2024
52-Week High Price (Date) Apr 08, 2024
Valuation APLI.TO - TSX Click to
Compare
Click to
Compare
Click to
Compare
Market Cap 2.54M
Enterprise Value 10.30M
Price/Earnings (TTM) --
Earnings Per Share (TTM) -0.02
Earnings Per Share Growth -26.69%
Price/Earnings To Growth --
Price/Sales (TTM) 42.86
Price/Book (Q) -0.38
Enterprise Value/Revenue (TTM) 115.04
Price $0.04
Enterprise Value/EBITDA (TTM) -1.42
Enterprise Value/EBIT -1.41
Market Cap Category Nano Cap
Dividends and Shares APLI.TO - TSX Click to
Compare
Click to
Compare
Click to
Compare
Shares Outstanding 121.27M
Dividend Yield --
Div. Per Share (Most Recent) --
Dividend Per Share (TTM) --
Payout Ratio (TTM) --
Dividend Per Share (Most Recent) --
Company Info APLI.TO - TSX Click to
Compare
Click to
Compare
Click to
Compare
Phone Number 902 442 4655
Address #21-1344 Summer Street Halifax, NS B3H 0A8
Website appilitherapeutics.com
Country Canada
Year Founded 2015
Profitability APLI.TO - TSX Click to
Compare
Click to
Compare
Click to
Compare
Operating Margin (TTM) -8,137.87%
Profit Margin -3,236.31%
Management Effectiveness APLI.TO - TSX Click to
Compare
Click to
Compare
Click to
Compare
Return on Assets -309.08%
Return on Equity --
Income Statement APLI.TO - TSX Click to
Compare
Click to
Compare
Click to
Compare
Revenue (TTM) 89.50K
Total Revenue (TTM) 89.50K
Revenue Per Share $0.00
Gross Profit (TTM) 89.50K
EBITDA (TTM) -7.27M
EBIT (TTM) -7.28M
Net Income (TTM) -2.90M
Net Income Avl. to Common (TTM) -2.90M
Total Revenue Growth (Q YOY) -77.99%
Earnings Growth (Q YOY) -234.46%
EPS Diluted (TTM) -0.02
EPS Diluted Growth (Q YOY) -244.44%
Balance Sheet APLI.TO - TSX Click to
Compare
Click to
Compare
Click to
Compare
Cash and Short-Term Inv. (Q) 129.40K
Cash Per Share (Q) $0.00
Total Current Assets (Q) 1.44M
Total Preferred Equity (Q) --
Total Equity (Q) -9.47M
Current Ratio (Q) 0.139
Book Value Per Share (Q) -$0.08
Total Assets (Q) 1.46M
Total Current Liabilities (Q) 10.36M
Total Debt (Q) 7.84M
Total Liabilities (Q) 10.93M
Total Common Equity (Q) -9.47M
Cash Flow APLI.TO - TSX Click to
Compare
Click to
Compare
Click to
Compare
Cash from Investing (TTM) -1.20K
Cash from Financing (TTM) 148.70K
Net Change in Cash (TTM) -301.40K
Levered Free Cash Flow (TTM) -5.59M
Cash from Operations (TTM) -451.30K
Weiss Ratings